-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellectar Biosciences 13G Filing Shows StemPoint Capital Reports 9.99% Stake In Co As Of June 30, 2026, Holding 845,740 Shares Including Pre-Funded Warrants

Benzinga·08/14/2026 16:17:00
Listen to the news

- SEC Filing